Compare PAYX & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAYX | GEHC |
|---|---|---|
| Founded | 1979 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.8B | 29.1B |
| IPO Year | 1995 | 2022 |
| Metric | PAYX | GEHC |
|---|---|---|
| Price | $100.56 | $65.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 13 |
| Target Price | ★ $111.67 | $88.38 |
| AVG Volume (30 Days) | 2.7M | ★ 4.4M |
| Earning Date | 03-25-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.59% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | ★ 3.71 | 0.85 |
| Revenue | $5,571,700,000.00 | ★ $20,625,000,000.00 |
| Revenue This Year | $19.19 | $7.12 |
| Revenue Next Year | $5.50 | $4.45 |
| P/E Ratio | ★ $26.78 | $75.99 |
| Revenue Growth | ★ 5.56 | 4.84 |
| 52 Week Low | $85.45 | $58.75 |
| 52 Week High | $154.90 | $89.77 |
| Indicator | PAYX | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 58.30 | 53.21 |
| Support Level | $87.59 | $60.80 |
| Resistance Level | $101.96 | $78.79 |
| Average True Range (ATR) | 2.71 | 1.60 |
| MACD | 0.14 | 0.46 |
| Stochastic Oscillator | 73.30 | 76.06 |
Paychex is a cloud-based human capital management provider offering payroll, compliance, talent management, benefits administration, and retirement services. The firm also provides HR outsourcing services, including professional employer organization, or PEO, offerings, enabling clients to reduce HR overhead. Paychex primarily targets small and midsize businesses, although its acquisition of Paycor in 2025 signals the firm's aspirations to expand into the midmarket segment, serving firms with more than 100 employees. As of fiscal 2025, Paychex has approximately 800,000 clients and manages payroll for one in 11 workers in the United States.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).